Clinical Oncological Dispensary of Omsk Region

Omsk 644013

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Transitional Cell, Castration-resistant Prostate Cancer, Lymphoma, Non-Hodgkin, Prostate Cancer Metastatic

Studies at this site

• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer — Completed
• Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma — Completed